General principles that must be applied to design of animal model |
Additional issues that must be considered to optimize the model |
Proper randomization of animals |
Models should be chosen on the basis of their relevance to the clinical situation, and not merely by the reproducibility of the model |
Similar baseline characteristics of the experimental groups |
Physiological parameters known to affect kidney function or susceptibility to injury should be controlled for, measured and reported (temperature, blood pressure, fluid status, type of anaesthesia, etc.) |
Concurrent appropriate controls |
Appropriate preparation of tissue for valid pathological interpretation |
Blinded assessment of outcome |
Fundamental requirements for a model should include morphology, haemodynamics and function |
Consideration and reporting of mortality |
Outcomes should be measures at multiple time points |
Numbers of animals studied should be appropriate to reproducibility of outcome measure |
Noninvasive biomarkers for renal parenchymal cell injury should be developed |
|
Models should be created that explicitly address comorbidities that are believed to predispose to acute renal failure and outcome in humans |
|
Experimental observations should be reproduced in other laboratories before they are generally accepted |